Welcome to our dedicated page for Vicarious Surgical news (Ticker: RBOT), a resource for investors and traders seeking the latest updates and insights on Vicarious Surgical stock.
Vicarious Surgical Inc. reports developments tied to its robotic surgery technology, financial results, and public-company status. The company is developing the Vicarious Surgical System for minimally invasive surgery, with updates covering benchtop and in-vivo testing, surgical instruments for ventral hernia repair, software engineering support, and progress toward system validation and clinical readiness.
Company news also covers operating expense trends, research and development spending, cash-burn discipline, and capital markets actions involving its Class A common stock. Recent disclosures include quotation on the OTCQB market after NYSE suspension and filings related to stockholder approval of a potential reverse stock split.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.